Close Menu

NEW YORK – The Centers for Medicare and Medicaid Services announced Wednesday it is increasing payments for high-throughput SARS-CoV-2 lab tests. 

CMS will pay $100 for SARS-CoV-2 diagnostic tests that use high-throughput technologies allowing for increased capacity and faster results. Labs can bill for these tests using code U0003 for PCR-based coronavirus tests and code U0004 for tests using any technique with high-throughput technology. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.